Related Experiment Video
Updated: Apr 30, 2026

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
Isolation and gut microbiota modulation of antibiotic-resistant probiotics from human feces
Peng Tian1, Bo Xu1, Hanxiao Sun1
1Institute of Genomic Medicine, College of Pharmacy, Jinan University, Guangzhou 510632, China.
Abstract:
Antibiotic-resistant probiotics may be advantageous for antibiotic-induced gut microbiota imbalance. In this article, we aimed to isolate antibiotic-resistant bacteria as potential probiotics. Feces from 3 healthy adults and 2 infants were used to isolate the antibiotic-resistant bacteria. Then we established gut microbiota imbalance mice model by antibiotics treatment and used it to assess the effect of the probiotics. Finally, we identified 8 isolates, and 6 of them were used as probiotics cocktail. Number of anaerobe, lactobacilli, and Bifidobacterium in feces were higher in the probiotic group (9.47±0.35 log10CFU/g, 8.74±0.18 log10CFU/g, 7.24±0.38 log10CFU/g, respectively) compared with model group (P<0.05). Richness and diversity index of probiotic group (19.79±0.29 and 2.95±0.06, respectively) were larger than model group (P<0.05). Diarrhea and mucosal edema had been alleviated during probiotic treatment. Our results validated that bacteriotherapy was available to treat gut microbiota imbalance.
Insights
Antibiotic-resistant probiotics can restore gut microbiota balance after antibiotic treatment. This study isolated resistant bacteria, showing they effectively improved gut health in mice, validating bacteriotherapy.
Area of Science:
- Microbiology
- Gastroenterology
- Probiotics Research
Background:
- Antibiotic use can disrupt the gut microbiota, leading to imbalance.
- Probiotics offer a potential therapeutic strategy to restore gut homeostasis.
- Antibiotic-resistant probiotics may be particularly beneficial in this context.
Purpose of the Study:
- To isolate antibiotic-resistant bacteria from human fecal samples for potential probiotic use.
- To evaluate the efficacy of these isolates in ameliorating antibiotic-induced gut microbiota imbalance in a mouse model.
- To validate bacteriotherapy as a treatment for gut dysbiosis.
Main Methods:
- Isolation of antibiotic-resistant bacteria from fecal samples of healthy adults and infants.
- Establishment of a gut microbiota imbalance mouse model using antibiotic treatment.
- Administration of a probiotic cocktail derived from isolated bacteria to the model mice.
- Assessment of fecal microbiota composition, diversity, and gut health indicators (diarrhea, mucosal edema).
Main Results:
- Eight antibiotic-resistant bacterial isolates were identified, with six formulated into a probiotic cocktail.
- Probiotic treatment significantly increased the abundance of anaerobes, lactobacilli, and Bifidobacterium compared to the model group.
- Gut microbiota richness and diversity indices were significantly higher in the probiotic-treated group.
- Symptoms such as diarrhea and mucosal edema were alleviated in the probiotic group.
Conclusions:
- Antibiotic-resistant bacteria can be effectively isolated and utilized as probiotics.
- Bacteriotherapy using these probiotics demonstrates efficacy in restoring gut microbiota balance and alleviating antibiotic-induced dysbiosis.
- The findings support the therapeutic potential of antibiotic-resistant probiotics for managing gut microbiota imbalances.
More Related Videos
Related Concept Videos
Probiotics
Functions of the Gut Microbiota
Introduction to the Human Microbiota
Development of Human Microbiota
Microbiota of the Large Intestine
Microbiota of the Stomach and Small Intestine

